Warfarin related to low rate of residual stroke in patients with atrial fibrillation
A review of clinical trials comparing warfarin with other medications for stroke prevention suggests that warfarin was associated with a low risk of stroke or non-central nervous system embolism in patients with nonvalvular ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
Poor health literacy increases risk of medication side-effects
The risk of serious side-effects associated with a common blood-thinning medication are related to elderly patients misunderstanding medical instructions, according to new research.
Medications
Mar 01, 2012 |
3 / 5 (1) |
0
Researchers find safer way to use common but potentially dangerous medication
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially ...
Medical research
Feb 29, 2012 |
3 / 5 (1) |
0
|
Stroke-preventing technology demonstrated in JoVE
In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million ...
Cardiology
Feb 28, 2012 |
not rated yet |
0
Warfarin and aspirin are similar in heart failure treatment
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking ...
Cardiology
Feb 03, 2012 |
not rated yet |
0
Rivaroxaban has less risk of brain bleeding in patients at high risk for stroke
For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke. The research ...
Cardiology
Feb 02, 2012 |
not rated yet |
0
Study finds warfarin underutilized in women
Dr. Rabab Mohsin, an internal medicine resident at the University of Kentucky, working with Dr. Alison Bailey of the University of Kentucky Gill Heart Institute, has discovered that the drug warfarin was underutilized in ...
Medications
Dec 13, 2011 |
not rated yet |
0
New method for safer dosing of anticoagulants
Elderly people with atrial fibrillation are often treated with anticoagulants to thin the blood, but this medicine is hard to dose and patients have to have their blood tested regularly. Researchers at the Sahlgrenska Academy ...
Other
Dec 06, 2011 |
not rated yet |
0
Blood clot risk halved for patients checking their own Warfarin dose
(Medical Xpress) -- Patients who monitor their own treatment with warfarin or other blood-thinning drugs reduce their risk of developing blood clots by half, an Oxford University study has found.
Diseases, Conditions, Syndromes
Dec 01, 2011 |
not rated yet |
0
|
Heart patients who take vitamins less likely to take medication as prescribed, according to study
Atrial Fibrillation patients who are prescribed the powerful blood thinner warfarin often take it with vitamins or supplements that can hamper its effectiveness, or skip doses completely, increasing their risk for stroke, ...
Cardiology
Nov 14, 2011 |
not rated yet |
1
ARISTOTLE trial finds new drug may revolutionize the treatment of atrial fibrillation
New research has the potential to revolutionize the treatment of atrial fibrillation (AF), a condition affecting a quarter of a million Canadians which is expected to strike even more in the coming years, as the Canadian ...
Cardiology
Oct 26, 2011 |
5 / 5 (2) |
0
Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives
A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreover, apixaban results in ...
Medical research
Aug 28, 2011 |
5 / 5 (3) |
1
|
Study shows ability of new agent to prevent strokes in patients with atrial fibrillation
In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting ...
Cardiology
Aug 10, 2011 |
3 / 5 (1) |
0
Thousands of patients prescribed high-risk drugs
Thousands of patients in Scotland who are particularly vulnerable to adverse drug events (ADEs) were prescribed high-risk medications by their GPs which could potentially cause them harm, according to research published in ...
Medications
Jun 22, 2011 |
3.5 / 5 (2) |
0
